Commentary and Research Papers
2024
2024
Exposure to innovative and transformative biotechnology companies has been a part of Pinnacle’s SMID investment strategy since our portfolio’s inception in 1996. Without a doubt, some of our most successful investments have come from this industry. Surprisingly, we have learned over the years that most investment managers avoid biotech stocks due to the inherent binary risks that come with drug development.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Stocks powered ahead in the first quarter, adding to strong fourth quarter gains. Continued enthusiasm for all things artificial intelligence (AI), along with US economic resilience and expectations for eventual rate cuts by the Federal Reserve, provided an attractive platform for equity market investors. An economic soft landing, deemed a far-fetched hope early in 2023, became the consensus call in the first quarter of 2024, as the fears of a Fed-induced recession faded.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Stocks continued their upward ascent in March, with investors gaining increased confidence in the economic environment. After looking over their shoulder toward the possibility of imminent recession over the past two years, investors finally seem to be coming around to the idea that maybe a recession is not in the cards. Continued resiliency in the economic data, despite a persistent inversion in the yield curve, and moderating inflation have increasingly made an economic soft landing a likely scenario. Late in the month, some investors were even calling for a “no landing” scenario, which means no interest rate cuts, but also means above-trend economic growth and more dependable corporate profit growth as we move through 2024.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
The February earnings season was a tumultuous few weeks for the Small Capitalization Value (SCV) Portfolio. We had several companies that produced fine 4th Quarter earnings but delivered somewhat cautious and/or disappointing forward outlooks.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Stocks resumed their upward momentum in February, led once again by the surging artificial-intelligence related stocks. New all-time records were hit for the Standard & Poors’ 500 and NASDAQ Composite, both of which have significant exposure to the large cap Technology stocks that are seen as the early winners in the AI boom. These index gains came despite the scaling back of interest rate cut expectations by investors vs. the end of 2023, when pundits were forecasting as many as seven rate cuts in 2024.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Pinnacle makes the case that current market conditions are encouraging for small caps to reward investors in its recent white paper entitled “It’s Time to Own U.S. Small Capitalization Equities,” as highlighted in a recent issue of Institutional Investor.
Read MoreRead MoreWatch Now
Founded in 1984, Pinnacle Associates, Ltd. is a forward thinking, multi-billion dollar investment advisory firm focused on transparency and putting clients first. We provide advice to individuals and families, institutional investors and other financial institutions.
